LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. today announced that three abstracts relating to CTP-499, its clinical candidate for the potential treatment of diabetic nephropathy, have been accepted for poster presentations at the American Society of Nephrology’s (ASN) Kidney Week 2011. The annual meeting will be held November 8-13, 2011 in Philadelphia, PA. Full abstracts can be viewed online at http://www.asn-online.org/education_and_meetings/kidneyweek/archives/.